These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


501 related items for PubMed ID: 24835773

  • 1. Anaphylaxis treatment: current barriers to adrenaline auto-injector use.
    Song TT, Worm M, Lieberman P.
    Allergy; 2014 Aug; 69(8):983-91. PubMed ID: 24835773
    [Abstract] [Full Text] [Related]

  • 2. What are the 'ideal' features of an adrenaline (epinephrine) auto-injector in the treatment of anaphylaxis?
    Frew AJ.
    Allergy; 2011 Jan; 66(1):15-24. PubMed ID: 20716315
    [Abstract] [Full Text] [Related]

  • 3. Anaphylaxis management: the essential role of adrenaline (epinephrine) auto-injectors. Should PHARMAC fund them in New Zealand?
    Fitzharris P, Empson M, Ameratunga R, Sinclair J, Crump V, Steele R, Broom B.
    N Z Med J; 2006 May 05; 119(1233):U1965. PubMed ID: 16680178
    [Abstract] [Full Text] [Related]

  • 4. Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community.
    Sheikh A, Simons FE, Barbour V, Worth A.
    Cochrane Database Syst Rev; 2012 Aug 15; 2012(8):CD008935. PubMed ID: 22895980
    [Abstract] [Full Text] [Related]

  • 5. Adrenaline in anaphylaxis treatment and self-administration: experience from an inner city emergency department.
    Mostmans Y, Grosber M, Blykers M, Mols P, Naeije N, Gutermuth J.
    Allergy; 2017 Mar 15; 72(3):492-497. PubMed ID: 27709624
    [Abstract] [Full Text] [Related]

  • 6. Epinephrine auto-injector pandemic.
    Campbell RL, Manivannan V, Hartz MF, Sadosty AT.
    Pediatr Emerg Care; 2012 Sep 15; 28(9):938-42. PubMed ID: 22940899
    [Abstract] [Full Text] [Related]

  • 7. Epinephrine auto-injectors: first-aid treatment still out of reach for many at risk of anaphylaxis in the community.
    Simons FE, World Allergy Organization.
    Ann Allergy Asthma Immunol; 2009 May 15; 102(5):403-9. PubMed ID: 19492662
    [Abstract] [Full Text] [Related]

  • 8. Is There an Optimal Training Interval to Improve the Correct Use of Adrenaline Auto-Injectors?
    Sirin Kose S, Asilsoy S, Tezcan D, Al S, Atay O, Kangalli O, Uzuner N, Karaman O.
    Int Arch Allergy Immunol; 2020 May 15; 181(2):136-140. PubMed ID: 31794965
    [Abstract] [Full Text] [Related]

  • 9. Epinephrine and its use in anaphylaxis: current issues.
    Simons KJ, Simons FE.
    Curr Opin Allergy Clin Immunol; 2010 Aug 15; 10(4):354-61. PubMed ID: 20543673
    [Abstract] [Full Text] [Related]

  • 10. Prevention of Anaphylaxis: The Role of the Epinephrine Auto-Injector.
    Fromer L.
    Am J Med; 2016 Dec 15; 129(12):1244-1250. PubMed ID: 27555092
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic and pharmacodynamic evidence of adrenaline administered via auto-injector for anaphylactic reactions: A review of literature.
    Moss J, Jani Y, Edwards B, Tomlin S, Rashed AN.
    Br J Clin Pharmacol; 2021 Mar 15; 87(3):816-824. PubMed ID: 32559814
    [Abstract] [Full Text] [Related]

  • 12. How far from correct is the use of adrenaline auto-injectors? A survey in Italian patients.
    Ridolo E, Montagni M, Bonzano L, Savi E, Peveri S, Costantino MT, Crivellaro M, Manzotti G, Lombardi C, Caminati M, Incorvaia C, Senna G.
    Intern Emerg Med; 2015 Dec 15; 10(8):937-41. PubMed ID: 25990486
    [Abstract] [Full Text] [Related]

  • 13. Management and treatment of anaphylaxis in children: still too low the rate of prescription and administration of intramuscular epinephrine.
    Calamelli E, Mattana F, Cipriani F, Ricci G.
    Int J Immunopathol Pharmacol; 2014 Dec 15; 27(4):597-605. PubMed ID: 25572739
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Current Situation of Treatment for Anaphylaxis in a Japanese Pediatric Emergency Center.
    Ninchoji T, Iwatani S, Nishiyama M, Kamiyoshi N, Taniguchi-Ikeda M, Morisada N, Ishibashi K, Iijima K, Ishida A, Morioka I.
    Pediatr Emerg Care; 2018 Apr 15; 34(4):e64-e67. PubMed ID: 27077998
    [Abstract] [Full Text] [Related]

  • 16. Diagnosis and treatment of anaphylaxis: there is an urgent needs to implement the use of guidelines.
    Ribeiro MLKK, Chong Neto HJ, Rosario Filho NA.
    Einstein (Sao Paulo); 2017 Apr 15; 15(4):500-506. PubMed ID: 29236793
    [Abstract] [Full Text] [Related]

  • 17. Timing the transfer of responsibilities for anaphylaxis recognition and use of an epinephrine auto-injector from adults to children and teenagers: pediatric allergists' perspective.
    Simons E, Sicherer SH, Simons FE.
    Ann Allergy Asthma Immunol; 2012 May 15; 108(5):321-5. PubMed ID: 22541402
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. When every second counts: ampoule versus adrenaline auto-injector administration for life-threatening allergy.
    McDonald EM, Cooper E.
    N Z Med J; 2019 Nov 08; 132(1505):79-82. PubMed ID: 31697666
    [No Abstract] [Full Text] [Related]

  • 20. Voluntarily reported unintentional injections from epinephrine auto-injectors.
    Simons FE, Edwards ES, Read EJ, Clark S, Liebelt EL.
    J Allergy Clin Immunol; 2010 Feb 08; 125(2):419-423.e4. PubMed ID: 20159254
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.